ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Drug combination overcomes barrier to effective melanoma immunotherapy – Medical Xpress

Medical XpressDrug combination overcomes barrier to effective melanoma immunotherapyMedical XpressImmunotherapies stimulate the CD8 T cells to attack tumors more vigorously. But the activity of CD8 T cells can be suppressed by other immune cells presen… Continue reading

2018-04-12 Michael Zand NEWS

Combination Immunotherapy Treatment for Mesothelioma “Significantly Prolonged Survival” – MesotheliomaHelp.org (blog)

MesotheliomaHelp.org (blog)Combination Immunotherapy Treatment for Mesothelioma “Significantly Prolonged Survival”MesotheliomaHelp.org (blog)Two drugs are often better than one for mesothelioma patients, with a combination of the chemotherapy drugs cis… Continue reading

2018-04-12 Michael Zand NEWS

Novartis’ $8.7bn AveXis deal shows gene therapy appeal – Chemistry World

Continue reading

2018-04-12 Michael Zand NEWS

Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer – European Pharmaceutical Review

European Pharmaceutical ReviewSimultaneous chemo and immunotherapy is effective in metastatic bladder cancerEuropean Pharmaceutical ReviewResearchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunothe… Continue reading

2018-04-12 Michael Zand NEWS

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno … – PR Newswire (press release)

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno …PR Newswire (press release)The Stem-to-T-Cell platform has the potential to address many types of cancer, including both solid and hematologica… Continue reading

2018-04-12 Michael Zand NEWS

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas – Technology Networks

Novartis’ $8.7bn AveXis deal shows gene therapy appeal
Chemistry World
This is Novartis’ second deal related to an AAV-based gene therapy. In January, it licensed marketing rights for Luxturna from Philadelphia, US-based Spark Therapeutics for $105 million up front and up to $65 million in milestone payments. In December …
Worldwide Cancer Gene Therapy Market Overview, Region Wise Analysis of Top Players and Feasibility Studies 2023Pharmaceuticals News
Cancer Gene Therapy Market to Record an Exponential CAGR by 2025The Columnist

all 4 news articles »

Continue reading

2018-04-12 Michael Zand NEWS

Synthetic Biology Market Analysis by Product Type, Applications, Regional Outlook, Technology, Opportunity – Investor Opinion

Synthetic Biology Market Analysis by Product Type, Applications, Regional Outlook, Technology, OpportunityInvestor OpinionSynthetic Biology Market 2025, presents a detailed analysis of current status of Synthetic Biology industry. The market report inc… Continue reading

2018-04-12 Michael Zand NEWS

A giant gorilla and a winged wolf: Does ‘Rampage’ get the science of CRISPR right? – STAT


Technology Networks

Lonza Opens World’s Largest Dedicated Cell-and-Gene–Therapy Manufacturing Facility in Texas
Technology Networks
… committed to the evolution and cultivation of a diverse medical and life-science community in the Greater Houston area for many years to come,” says Marc Funk, Lonza Pharma & Biotech Chief Operating Officer. “The site is well positioned to meet the …

Continue reading

2018-04-12 Michael Zand NEWS
  • 1
  • …
  • 264
  • 265
  • 266
  • 267
  • 268
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

STAT

A giant gorilla and a winged wolf: Does ‘Rampage’ get the science of CRISPR right?
STAT
e here at STAT cover CRISPR 1 a lot. But it’s not every day we get to cover Dwayne “The Rock” Johnson. The Rock and the genome-editing technology meet in a new movie, “Rampage 2,” coming out Friday. Through a freak accident, a gorilla, a wolf, and a …